Clinical Trial Update: Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

This update reports on a Phase 2 trial evaluating combination chemotherapy in younger patients with Hodgkin lymphoma. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: University College, London | Conditions: Lymphoma, Neurotoxicity | Phase 2 | Status: COMPLETED